Hemophilia Research Today is a free monthly online journal that collates and summarizes the latest research about Hemophilia, including details on genetics, causes, symptoms, blood transfusion.

Volume 1 (2005), Issue 4 (April)

1. Thrombosis in a pregnant hemophilia A carrier after intrapartum recombinant factor VIII.
   Obstet Gynecol, 105(4): 875-6. [Abstract] [Full-text]
2. Acquired haemophilia in a patient with gram-negative urosepsis and bladder cancer.
   Haemophilia, 11(2): 181-5. [Abstract] [Full-text]
3. Orthopaedic manifestations of the hip in haemophilia--impaction bone grafting used in revision total hip arthroplasty in a haemophilic patient.
   Haemophilia, 11(2): 175-7. [Abstract] [Full-text]
4. Acquired factor VIII inhibitor presenting as macular haemorrhage.
   Haemophilia, 11(2): 164-6. [Abstract] [Full-text]
5. A framework for genetic service provision for haemophilia and other inherited bleeding disorders.
   Haemophilia, 11(2): 145-63. [Abstract] [Full-text]
6. Utility of a (GT) dinucleotide repeat in intron 1 of the factor 8 gene for haemophilia A carrier diagnosis.
   Haemophilia, 11(2): 142-4. [Abstract] [Full-text]
7. Mutation analysis in 51 patients with haemophilia A: report of 10 novel mutations and correlations between genotype and clinical phenotype.
   Haemophilia, 11(2): 133-41. [Abstract] [Full-text]
8. An exploration of health-related quality of life in adults with haemophilia--a qualitative perspective.
   Haemophilia, 11(2): 123-32. [Abstract] [Full-text]
9. MRI scores of ankle joints in children with haemophilia--comparison with clinical data.
   Haemophilia, 11(2): 116-22. [Abstract] [Full-text]
10. Compatible scales for progressive and additive MRI assessments of haemophilic arthropathy.
    Haemophilia, 11(2): 109-15. [Abstract] [Full-text]
11. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
    Haemophilia, 11(2): 100-6. [Abstract] [Full-text]
12. Changing pattern of care of boys with haemophilia in western European centres.
    Haemophilia, 11(2): 92-9. [Abstract] [Full-text]
13. B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study.
    Haemophilia, 11(2): 84-91. [Abstract] [Full-text]
14. Prophylactic treatment effects on inhibitor risk: experience in one centre.
    Haemophilia, 11(2): 79-83. [Abstract] [Full-text]
15. FVIII gene delivery by muscle electroporation corrects murine hemophilia A.
    J Gene Med, 7(4): 494-505. [Abstract] [Full-text]
16. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
17. Efficacy of auxiliary partial orthotopic liver transplantation for cure of hemophilia in a canine hemophilia A model.
    Transplant Proc, 37(2): 1131-3. [Abstract] [Full-text]
18. Preclinical experiment of auxiliary partial orthotopic liver transplantation as a curative treatment for hemophilia.
    Liver Transpl, 11(5): 579-84. [Abstract] [Full-text]
19. Familial nonrandom inactivation linked to the X inactivation centre in heterozygotes manifesting haemophilia A.
    Eur J Hum Genet, 13(5): 635-40. [Abstract] [Full-text]
20. Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy.
    Proc Natl Acad Sci U S A, 102(17): 6080-5. [Abstract] [Full-text]
21. Successful use of recombinant factor VIIa for emergency fasciotomy in a patient with hemophilia A and high-titer inhibitor unresponsive to factor VIII inhibitor bypassing activity.
    Am J Hematol, 79(1): 58-60. [Abstract] [Full-text]
22. Prevalence and risk factors for heart disease among males with hemophilia.
    Am J Hematol, 79(1): 36-42. [Abstract] [Full-text]

© 2005-2008 Hemophilia Research Today. All Rights Reserved.